210 related articles for article (PubMed ID: 17387676)
1. Another paradox in Crohn's disease: new onset of psoriasis in a patient receiving tumor necrosis factor-alpha antagonist.
Angelucci E; Cocco A; Viscido A; Vernia P; Caprilli R
Inflamm Bowel Dis; 2007 Aug; 13(8):1059-61. PubMed ID: 17387676
[No Abstract] [Full Text] [Related]
2. Psoriasis and psoriatic arthritis induced in a patient treated with infliximab for Crohn's disease.
Tichy M; Tichy M; Kopova R; Sternbersky J; Ditrichova D
J Dermatolog Treat; 2012 Jun; 23(3):208-11. PubMed ID: 21254868
[TBL] [Abstract][Full Text] [Related]
3. Onset of flexural psoriasis during infliximab treatment for Crohn's disease.
Peramiquel L; Puig L; Dalmau J; Ricart E; Roe E; Alomar A
Clin Exp Dermatol; 2005 Nov; 30(6):713-4. PubMed ID: 16197398
[No Abstract] [Full Text] [Related]
4. Psoriasiform and pustular eruption induced by infliximab.
Takahashi H; Hashimoto Y; Ishida-Yamamoto A; Ashida T; Kohgo Y; Iizuka H
J Dermatol; 2007 Jul; 34(7):468-72. PubMed ID: 17584325
[TBL] [Abstract][Full Text] [Related]
5. Psoriasis induced by infliximab in a patient suffering from Crohn's disease.
Manni E; Barachini P
Int J Immunopathol Pharmacol; 2009; 22(3):841-4. PubMed ID: 19822070
[TBL] [Abstract][Full Text] [Related]
6. Guttate psoriasis induced by infliximab in a child with Crohn's disease.
Costa-Romero M; Coto-Segura P; Suarez-Saavedra S; Ramos-Polo E; Santos-Juanes J
Inflamm Bowel Dis; 2008 Oct; 14(10):1462-3. PubMed ID: 18383177
[No Abstract] [Full Text] [Related]
7. Development of diffuse psoriasis with alopecia during treatment of Crohn's disease with infliximab.
Medkour F; Babai S; Chanteloup E; Buffard V; Delchier JC; Le-Louet H
Gastroenterol Clin Biol; 2010 Feb; 34(2):140-1. PubMed ID: 20138448
[No Abstract] [Full Text] [Related]
8. Infliximab-induced psoriasis during therapy for Crohn's disease.
Steinwurz F; Denadai R; Saad-Hossne R; Queiroz ML; Teixeira FV; Romiti R
J Crohns Colitis; 2012 Jun; 6(5):610-6. PubMed ID: 22398095
[TBL] [Abstract][Full Text] [Related]
9. Infliximab-associated psoriasis in children with Crohn's disease may require withdrawal of anti-tumor necrosis factor therapy.
Broge T; Nguyen N; Sacks A; Davis M
Inflamm Bowel Dis; 2013 Apr; 19(5):E75-7. PubMed ID: 23435403
[No Abstract] [Full Text] [Related]
10. Generalized pustular psoriasis triggered by infliximab in two patients with Crohn's disease.
Kato Y; Yamamoto T
J Dermatol; 2013 Nov; 40(11):932-3. PubMed ID: 24127642
[No Abstract] [Full Text] [Related]
11. Severe pneumococcal pneumonia following treatment with infliximab for Crohn's disease.
Ritz MA; Jost R
Inflamm Bowel Dis; 2001 Nov; 7(4):327. PubMed ID: 11720324
[No Abstract] [Full Text] [Related]
12. Pericarditis as a complication of infliximab therapy in Crohn's disease.
Burke JP; Kelleher B; Ramadan S; Quinlan M; Sugrue D; O'Donovan MA
Inflamm Bowel Dis; 2008 Mar; 14(3):428-9. PubMed ID: 17924565
[No Abstract] [Full Text] [Related]
13. Severe agranulocytosis following first infliximab infusion in Crohn's disease.
Rosales-Zábal JM; Fernández-Pérez F; Albandea-Moreno C; Vera-Rivero FM; Navarro-Jarabo JM
Inflamm Bowel Dis; 2011 Nov; 17(11):E147-8. PubMed ID: 21830280
[No Abstract] [Full Text] [Related]
14. Infliximab-induced thrombocytopenia in an elderly patient with ileocolonic Crohn's disease.
Mocciaro F; Russo G; Di Mitri R; Marino A
Inflamm Bowel Dis; 2013; 19(4):E52-3. PubMed ID: 22535599
[No Abstract] [Full Text] [Related]
15. Development of psoriasis scalp with alopecia during treatment of Crohn's disease with infliximab and rapid response to both diseases to ustekinumab.
Andrisani G; Marzo M; Celleno L; Guidi L; Papa A; Gasbarrini A; Armuzzi A
Eur Rev Med Pharmacol Sci; 2013 Oct; 17(20):2831-6. PubMed ID: 24174369
[TBL] [Abstract][Full Text] [Related]
16. Severe Listeria meningoencephalitis in an infliximab-treated patient with Crohn's disease.
Izbéki F; Nagy F; Szepes Z; Kiss I; Lonovics J; Molnár T
Inflamm Bowel Dis; 2008 Mar; 14(3):429-31. PubMed ID: 17973302
[No Abstract] [Full Text] [Related]
17. [Psoriasis induced by infliximab].
Fernandes IC; Torres T; Sanches M; Velho G; Lago P; Selores M
Acta Med Port; 2011 Dec; 24 Suppl 3():709-12. PubMed ID: 22856418
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody therapy for Crohn's disease.
Selby W
Intern Med J; 2001 Mar; 31(2):73-4. PubMed ID: 11480481
[No Abstract] [Full Text] [Related]
19. Anti-TNF therapy for Crohn's disease: a perspective (infliximab is not the drug we have been waiting for).
Shanahan F
Inflamm Bowel Dis; 2000 May; 6(2):137-9. PubMed ID: 10833074
[No Abstract] [Full Text] [Related]
20. Neurological symptoms suggestive of demyelination in Crohn's disease after infliximab therapy.
Dubcenco E; Ottaway CA; Chen DL; Baker JP
Eur J Gastroenterol Hepatol; 2006 May; 18(5):565-6. PubMed ID: 16607158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
